The global tomosynthesis market had a valuation of USD 1.2 billion in 2022 and is projected to reach USD 3.6 billion by 2032, with a compound annual growth rate (CAGR) of 12.5% during the forecast period. The market growth is primarily fueled by key factors such as the increasing prevalence of breast cancer, the aging population, and advancements in medical imaging technology. Breast cancer is a leading cause of death among women worldwide, and its incidence is rising due to various factors such as exposure to radiation, sedentary lifestyles. https://www.reportsanddata.com..../report-detail/tomos